Pre-Exposure Prophylaxis (PrEP)
TRUVADA for PrEP (pre-exposure prophylaxis) is a prescription medicine that can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices. This use is only for people who weigh at least 77 pounds and are HIV-negative and at risk of getting HIV-1.
Post-Exposure Prophylaxis (PEP)
Key Points
- Post-exposure prophylaxis (PEP) involves taking HIV medicines very soon after a possible exposure to HIV to prevent becoming infected with HIV.
- PEP is intended for emergency situations. It is not meant for regular use by people who may be exposed to HIV frequently.
- PEP must be started as soon as possible to be effective and always within 72 hours (3 days) after a possible exposure to HIV.
- PEP involves taking HIV medicines every day for 28 days.
PEP & PrEP Baseline Lab
KRW 325,000 (NHS: KRW 54,000)
|
Follow-up HIV testing
| Timing | Testing |
|---|---|
| Baseline | Rapid blood HIV test + laboratory 4th-generation Ag/Ab |
| 4-6 weeks after PEP initiation | Laboratory Ag/Ab + HIV RNA NAT |
| 12 weeks after exposure | Laboratory Ag/Ab + HIV RNA NAT |